07.15.11
Wenzel Spine Inc. has surpassed 26,000 successful implantations of its Stand-Alone VariLift Expandable Interbody Fusion Device.
“We are pleased to reach this significant milestone,” said Chad Neely, CEO of the Austin, Texas-based company. “VariLift has experienced tremendous success worldwide and we look forward to achieving the same success in the U.S. as we begin our full market release with the 2011 launch of VariLift.”
The VariLift System provides a minimally invasive, stand-alone solution for interbody fusion procedures. The technology is used in single or two contiguous levels in the lumbar spine (L2-S1) for treatment of degenerative disc disease and related instability. It is approved by the U.S. Food and Drug Administration (FDA) for posterior, transforaminal, and anterior lumbar interbody fusion applications and without supplemental fixation.
“VariLift is an exciting option for spine surgeons performing lumbar fusion surgery as it creates immediate stability and fixation by expanding in-situ once it’s properly positioned,” said Daniel Peterson, M.D., clinical adjunct professor of biomedical engineering at the University of Texas in Austin.
The system received CE Mark approval in November 2010, along with VariLift-C, a cervical device design and application. It currently is the only FDA-cleared, stand-alone interbody fusion device that expands in-situ, without pedicle screws and rods, providing a minimally invasive alternative to traditional spinal fusion.
“We are pleased to reach this significant milestone,” said Chad Neely, CEO of the Austin, Texas-based company. “VariLift has experienced tremendous success worldwide and we look forward to achieving the same success in the U.S. as we begin our full market release with the 2011 launch of VariLift.”
The VariLift System provides a minimally invasive, stand-alone solution for interbody fusion procedures. The technology is used in single or two contiguous levels in the lumbar spine (L2-S1) for treatment of degenerative disc disease and related instability. It is approved by the U.S. Food and Drug Administration (FDA) for posterior, transforaminal, and anterior lumbar interbody fusion applications and without supplemental fixation.
“VariLift is an exciting option for spine surgeons performing lumbar fusion surgery as it creates immediate stability and fixation by expanding in-situ once it’s properly positioned,” said Daniel Peterson, M.D., clinical adjunct professor of biomedical engineering at the University of Texas in Austin.
The system received CE Mark approval in November 2010, along with VariLift-C, a cervical device design and application. It currently is the only FDA-cleared, stand-alone interbody fusion device that expands in-situ, without pedicle screws and rods, providing a minimally invasive alternative to traditional spinal fusion.